TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: >1.00E+3nMAssay Description:Inhibition of ZIPKMore data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: >1.39E+3nMAssay Description:Inhibition of ZIPkMore data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.80nMAssay Description:Inhibition of human ZIPK using KKLNRTLSFAEPG as substrate by [gamma-33P]-ATP assayMore data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 3.5nMAssay Description:Inhibition of human ZIPK using KKLNRTLSFAEPG as substrate by [gamma-33P]-ATP assayMore data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 10nMAssay Description:Inhibition of Dapk3 (unknown origin) at by quantitative PCRMore data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 17nMAssay Description:Inhibition of recombinant human DAPK3 in presence of ATP at Km concentration by radiometric filter-binding assayMore data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 17nMAssay Description:Inhibition of human recombinant DAPK3 by radiometric assayMore data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 140nMAssay Description:Inhibition of DAPK3 (unknown origin)More data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 148nMAssay Description:Inhibition of human recombinant DAPK3More data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 157nMAssay Description:Inhibition of human recombinant DAPK3More data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 227nMAssay Description:Inhibition of human recombinant DAPK3More data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 260nMAssay Description:Inhibition of human DAPK3More data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 279nMAssay Description:Inhibition of human recombinant DAPK3More data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 279nMAssay Description:Inhibition of human recombinant DAPK3More data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 291nMAssay Description:Inhibition of human recombinant DAPK3More data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 346nMAssay Description:Inhibition of human recombinant DAPK3More data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 360nMAssay Description:Inhibition of human recombinant DAPK3More data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 395nMAssay Description:Inhibition of human recombinant DAPK3More data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 450nMAssay Description:Inhibition of DAPK3 (unknown origin)More data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 510nMAssay Description:Inhibition of DAPK3 (unknown origin)More data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 530nMAssay Description:Inhibition of human recombinant DAPK3More data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 534nMAssay Description:Inhibition of human recombinant DAPK3More data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 578nMAssay Description:Inhibition of human DAPK3 in presence of ATP by kinomescan assayMore data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 583nMAssay Description:Inhibition of human recombinant DAPK3More data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 700nMAssay Description:Inhibition of DAPK3 (unknown origin)More data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 714nMAssay Description:Inhibition of human recombinant DAPK3More data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 720nMAssay Description:Inhibition of recombinant human ZIPK (1 to 290 residues) using KKLNRTLSFAEPG substrate incubated for 40 mins in presence of [gamma33P]ATP by scintill...More data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >1.00E+3nMAssay Description:Inhibition of ZipKMore data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibition of DAPK3 (unknown origin)More data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibition of DAPK3 (unknown origin)More data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.60E+3nMAssay Description:Inhibition of ZIPK (unknown origin) after 60 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.80E+3nMAssay Description:Inhibition of DAPK3 (unknown origin)More data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 2.33E+3nMAssay Description:Inhibition of human DAPK3More data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 4.30E+3nMAssay Description:Inhibition of ZIPKMore data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 4.86E+3nMAssay Description:Inhibition of ZIPK (unknown origin) after 60 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 4.98E+3nMAssay Description:Inhibition of ZIPK (unknown origin) after 60 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of recombinant human ZIPK (1 to 290 residues) using KKLNRTLSFAEPG substrate incubated for 40 mins in presence of [gamma33P]ATP by radiomet...More data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of ZIPK (unknown origin)More data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of ZIPK (unknown origin) after 60 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of ZIPK (unknown origin) after 60 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of ZIPK (unknown origin)More data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of DAPK3 (unknown origin)More data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: <1.00E+4nMAssay Description:Inhibition of DAPK3 by FRET assayMore data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of human ZIPK using [KKLNRTLSFAEPG] as substrateMore data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of recombinant human ZIPK (1 to 290 residues) using KKLNRTLSFAEPG as substrate measured after 40 mins in presence of [gamma33P]ATP by radi...More data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.22E+4nMAssay Description:Inhibition of human DAPK3More data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.89E+4nMAssay Description:Inhibition of human DAPK3More data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >3.00E+4nMAssay Description:Inhibition of ZIPKMore data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 3.20E+4nMAssay Description:Inhibition of ZIPKMore data for this Ligand-Target Pair
TargetDeath-associated protein kinase 3(Homo sapiens (Human))
Vertex Pharmaceuticals
Curated by ChEMBL
Vertex Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 3.98E+4nMAssay Description:Inhibition of human DAPK3More data for this Ligand-Target Pair
![](/img/powered_by_small.gif)